Anondita Medicare IPO
LiveAlready have an account? Apply now
Schedule of Anondita Medicare
| Issue open date | 22 Aug 2025 |
| Issue close date | 26 Aug 2025 |
| UPI mandate deadline | 26 Aug 2025 (5PM) |
| Allotment finalization | 28 Aug 2025 |
| Refund initiation | 29 Aug 2025 |
| Share credit | 29 Aug 2025 |
| Listing date | 01 Sep 2025 |
| Mandate end date | 10 Sep 2025 |
| Lock-in end date for anchor investors (50%) | 27 Sep 2025 |
| Lock-in end date for anchor investors (remaining) | 26 Nov 2025 |
Note: The schedule is tentative. The anchor lock-in period ends 30 days after the actual allotment date for 50% of the shares and 90 days after for the remaining portion. The allotment status can be checked on the registrar's website and the exchange website.
About Anondita Medicare
Anondita Medicare Limited, incorporated in 1990, is engaged in the manufacturing and marketing of sexual wellness products. Its flagship brand “COBRA” is one of the well-recognized condom brands in India. The company operates a large-scale facility with an installed capacity of 562 million condoms annually, supported by modern testing and quality control systems. Over the years, Anondita has expanded its distribution network across India while also catering to international markets through exports. The company has a workforce of skilled employees and maintains certifications to meet global quality and safety standards.
Financials of Anondita Medicare
Issue size
| Funds Raised in the IPO | Amount |
| Overall | ₹69.50 crores |
| Fresh Issue | ₹69.50 crores |
Utilisation of proceeds
| Purpose | INR crores (%) |
| Capital expenditure | 6 (8.64%) |
| Working capital requirement | 35 (50.36%) |
| General corporate purposes and miscellaneous | 28.5 (41%) |
Strengths
- Established brand presence with flagship “COBRA” condoms.
- Long-standing relationships with distributors and institutional buyers.
- Wide product portfolio in the sexual wellness segment.
- In-house quality testing ensures global compliance standards.
- Experienced promoters with three decades of industry knowledge.
Risks
- High dependence on limited customers for revenues.
- Majority revenue concentrated from sale of condoms.
- Exposure to government tender-based order fluctuations.
- Subject to strict regulatory and quality requirements.
- Foreign exchange fluctuations impacting export revenues.
Allotment Status for Anondita Medicare
To check your allotment status – click here.
Subscription Figures for Anondita Medicare
As per media reports (Link), the Grey Market Premium (GMP) of Anondita Medicare is reported at ₹22 over the IPO price. This metric is not reliable, and to track IPO interest, it is better to check subscription numbers published by exchanges, which are considered more reliable indicators.
Subscription numbers as of 5:00 PM on August 22, 2025:
| Category | Reserved (lakhs) | Applied (lakhs) | Subscription (X times) |
|---|---|---|---|
| Institutional | 9.06 | 1.03 | 0.11x |
| NII | 6.81 | 13.11 | 1.93x |
| Retail | 15.86 | 92.86 | 5.85x |
| Total | 31.73 | 107.00 | 3.37x |